BLS Polymers IPO Analysis: Should You Apply? GMP, Review & Details

BLS Polymers is a MAINBOARD IPO in the Plastic Products - Industrial sector. The issue price band is ₹142.0–₹150.0 per share. Issue size is ₹255.0 crore. Current GMP is +25.33% over the issue price (unofficial, subject to change).

BLS Polymers IPO — Key Details

Company Overview

BLS Polymers is a prominent manufacturer of custom-formulated polymer compounds, primarily serving critical infrastructure sectors such as telecommunications, power, railways, water, and oil & gas distribution. The company's diverse product range includes various types of polyethylene, halogen-free flame retardant compounds, polyvinyl chloride, cable filling compounds, and adhesive coating compounds. With a strong presence across 24 states and union territories in India, BLS Polymers has a significant domestic and international customer base, with 91.57% of its revenue coming from domestic operations in Fiscal 2025.

Financial Performance

For the period ending June 30, 2026, total income was ₹107.81 Cr, a decrease from ₹354.41 Cr for the full year ending March 31, 2026. This decline is notable as the June figure represents a 9-month period, not a full fiscal year, making direct comparisons challenging. Prior to that, total income was ₹336.70 Cr for the year ending March 31, 2025, showing a consistent revenue trend over the previous years. Profit After Tax was ₹10.23 Cr for the period ending June 30, 2026, down from ₹27.01 Cr for the year ending March 31, 2026. This reduction also reflects the shorter reporting period, which is not directly comparable to a full fiscal year. The profit for the year ending March 31, 2025, was ₹21.14 Cr, indicating a progressive growth in profitability prior to the most recent period.

Objects of the Issue

The company plans to use the proceeds from the issue for several purposes: ₹77.56 Cr for expanding its manufacturing facility, ₹89.50 Cr for funding working capital requirements, and the remainder for general corporate purposes.

Strengths & Weaknesses

Strengths

BLS Polymers boasts a diversified product portfolio and has established long-standing relationships with customers. Its strong presence across India and its enlistment with prominent government agencies enhance its competitive edge.

Understanding Grey Market Premium (GMP)

The Grey Market Premium (GMP) is an unofficial indicator of an IPO's expected listing price. It reflects the price at which shares are being traded in the grey market before they are officially listed. A positive GMP suggests strong demand, while a negative GMP may indicate weak interest.

Peer Comparison

• BLS Polymers Limited: P/E of 25, EPS of ₹6.00
• Plastiblends India Ltd.: P/E of 14.53, EPS of ₹14.12
• Ddev Plastiks Industries Ltd.: P/E of 12.97, EPS of ₹19.5
• Kingfa Science & Technology (India) Ltd.: P/E of 46.25, EPS of ₹144.1

IPO Timeline

The IPO opens for subscription on October 27, 2026, and closes on October 29, 2026. Allotment of shares is expected by October 30, 2026, with the listing date set for November 3, 2026.

Should You Apply for BLS Polymers IPO?

Investors comfortable with short-term volatility and a long-term horizon typically weigh IPOs like this against their investment goals and risk tolerance. Factors such as the company's growth potential, market conditions, and financial health should be considered.

Conservative investors or those averse to risk may want to avoid IPOs like this, especially if they are uncomfortable with potential price fluctuations or the uncertainties associated with new market entrants.

This is general risk-profile education, not a personal recommendation to apply or avoid this specific IPO — TopFund is not a SEBI-registered investment adviser.

Listing Day Risks

Listing gains refer to the potential profit an investor can make when shares are listed on the stock exchange for the first time. However, these gains are not guaranteed and can be influenced by market conditions, investor sentiment, and the company's performance post-listing. Investors should be aware of the risks involved in relying solely on listing gains.

Trending Searches

Disclaimer: This is educational content, not investment advice. GMP is an unofficial grey-market indicator, unregulated and never guaranteed. TopFund is not a SEBI-registered investment adviser — please do your own research or consult a qualified adviser before applying to any IPO.